[Evolution of antibiograms of bacilli persisting under treatment in the sanatorium].
D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use*; D003523:Cycloserine / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D005000:Ethionamide / Q000627:therapeutic use; D006782:Hospitals, Special; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D007612:Kanamycin / Q000627:therapeutic use; D008722:Methods; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D013307:Streptomycin / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*; D014756:Viomycin / Q000627:therapeutic use
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D007612:Kanamycin; D003523:Cycloserine; D005000:Ethionamide; D007538:Isoniazid; D013307:Streptomycin; D014756:Viomycin
Evolution ds antibiogrammes des bacilles persistant sous traitment en sanatorium.